• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症的社会决定因素。

Social determinants of health in multiple sclerosis.

机构信息

Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.

Department of Neurology, Royal London Hospital, London, UK.

出版信息

Nat Rev Neurol. 2022 Dec;18(12):723-734. doi: 10.1038/s41582-022-00735-5. Epub 2022 Nov 11.

DOI:10.1038/s41582-022-00735-5
PMID:36369488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9651126/
Abstract

Social determinants of health are the conditions in which people are born, grow, live, work and age. These circumstances are the non-medical factors that influence health outcomes. Evidence indicates that health behaviours, comorbidities and disease-modifying therapies all contribute to multiple sclerosis (MS) outcomes; however, our knowledge of the effects of social determinants - that is, the 'risks of risks' - on health has not yet changed our approach to MS. Assessing and addressing social determinants of health could fundamentally improve health and health care in MS; this approach has already been successful in improving outcomes in other chronic diseases. In this narrative Review, we identify and discuss the body of evidence supporting an effect of many social determinants of health, including racial background, employment and social support, on MS outcomes. It must be noted that many of the published studies were subject to bias, and screening tools and/or practical interventions that address these social determinants are, for the most part, lacking. The existing work does not fully explore the potential bidirectional and complex relationships between social determinants of health and MS, and the interpretation of findings is complicated by the interactions and intersections among many of the identified determinants. On the basis of the reviewed literature, we consider that, if effective interventions targeting social determinants of health were available, they could have substantial effects on MS outcomes. Therefore, funding for and focused design of studies to evaluate and address social determinants of health are urgently needed.

摘要

社会决定因素是人们出生、成长、生活、工作和衰老的环境。这些环境是非医疗因素,会影响健康结果。有证据表明,健康行为、合并症和疾病修正疗法都对多发性硬化症 (MS) 结局有影响;然而,我们对社会决定因素(即“风险的风险”)对健康的影响的认识尚未改变我们对 MS 的治疗方法。评估和解决健康的社会决定因素可以从根本上改善 MS 患者的健康和医疗服务;这种方法已经在改善其他慢性疾病的结局方面取得了成功。在这篇叙述性综述中,我们确定并讨论了支持许多健康社会决定因素(包括种族背景、就业和社会支持)对 MS 结局有影响的证据。必须指出的是,许多已发表的研究都存在偏倚,而且针对这些社会决定因素的筛查工具和/或实际干预措施在很大程度上是缺乏的。现有研究并未充分探讨健康的社会决定因素与 MS 之间潜在的双向和复杂关系,而且由于所确定的许多决定因素之间的相互作用和交叉,对研究结果的解释变得复杂。基于综述文献,我们认为,如果有针对健康的社会决定因素的有效干预措施,它们可能会对 MS 结局产生重大影响。因此,迫切需要为评估和解决健康的社会决定因素提供资金并进行有针对性的研究设计。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5318/9651126/78ec64bc0d0d/41582_2022_735_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5318/9651126/67b9b236ff9a/41582_2022_735_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5318/9651126/78ec64bc0d0d/41582_2022_735_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5318/9651126/67b9b236ff9a/41582_2022_735_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5318/9651126/78ec64bc0d0d/41582_2022_735_Fig2_HTML.jpg

相似文献

1
Social determinants of health in multiple sclerosis.多发性硬化症的社会决定因素。
Nat Rev Neurol. 2022 Dec;18(12):723-734. doi: 10.1038/s41582-022-00735-5. Epub 2022 Nov 11.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.超越黑木树:影响澳大利亚地区、农村和偏远地区的健康研究问题的快速综述。
Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881.
4
Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.促进和支持社区中患有慢性身体疾病的成年人进行自我管理:对医患互动的有效性和意义的系统评价。
JBI Libr Syst Rev. 2009;7(13):492-582. doi: 10.11124/01938924-200907130-00001.
5
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
6
Information provision for people with multiple sclerosis.为多发性硬化症患者提供信息。
Cochrane Database Syst Rev. 2014 Apr 21(4):CD008757. doi: 10.1002/14651858.CD008757.pub2.
7
Achieving Health Equity in Hypertension Management Through Addressing the Social Determinants of Health.通过解决健康的社会决定因素实现高血压管理中的健康公平。
Curr Hypertens Rep. 2019 Jun 12;21(8):58. doi: 10.1007/s11906-019-0962-7.
8
Health Disparities, Inequities, and Social Determinants of Health in Multiple Sclerosis and Related Disorders in the US: A Review.美国多发性硬化症及相关疾病的健康差异、不平等和社会决定因素:综述。
JAMA Neurol. 2021 Dec 1;78(12):1515-1524. doi: 10.1001/jamaneurol.2021.3416.
9
Squinting through layers of fog: assessing the cost effectiveness of treatments for multiple sclerosis.透过层层迷雾审视:评估多发性硬化症治疗的成本效益。
Appl Health Econ Health Policy. 2013 Aug;11(4):331-41. doi: 10.1007/s40258-013-0034-0.
10
Managing communication changes in persons with multiple sclerosis: Findings from qualitative focus groups.管理多发性硬化症患者的沟通变化:定性焦点小组的发现。
Int J Lang Commun Disord. 2022 May;57(3):680-694. doi: 10.1111/1460-6984.12717. Epub 2022 Mar 26.

引用本文的文献

1
Effects of psychological therapies in people with multiple sclerosis: a systematic review and network meta-analysis of randomized controlled trials.心理疗法对多发性硬化症患者的影响:随机对照试验的系统评价和网状Meta分析
J Neurol. 2025 Aug 20;272(9):584. doi: 10.1007/s00415-025-13315-6.
2
Completeness and generalizability of the Swedish MS register.瑞典多发性硬化症登记册的完整性和普遍性
Eur J Epidemiol. 2025 Jul 24. doi: 10.1007/s10654-025-01276-z.
3
Multiple Sclerosis in People of Diverse Racial and Ethnic Backgrounds: Presentation, Disease Course, and Interactions with Disease-Modifying Therapy.

本文引用的文献

1
Towards a global view of multiple sclerosis genetics.迈向多发性硬化症遗传学的全球视野。
Nat Rev Neurol. 2022 Oct;18(10):613-623. doi: 10.1038/s41582-022-00704-y. Epub 2022 Sep 8.
2
From the prodromal stage of multiple sclerosis to disease prevention.从多发性硬化症的前驱期到疾病预防。
Nat Rev Neurol. 2022 Sep;18(9):559-572. doi: 10.1038/s41582-022-00686-x. Epub 2022 Jul 15.
3
Global developments in social prescribing.社会处方的全球发展。
不同种族和族裔背景人群中的多发性硬化症:临床表现、疾病进程以及与疾病修正治疗的相互作用
CNS Drugs. 2025 Jul 18. doi: 10.1007/s40263-025-01205-4.
4
Comparative Effectiveness of Fumarates Versus Sphingosine-1-Phosphate Receptor Modulators in Black Patients with Multiple Sclerosis.富马酸盐与1-磷酸鞘氨醇受体调节剂对黑人多发性硬化症患者的疗效比较
Neurol Ther. 2025 Jun 16. doi: 10.1007/s40120-025-00774-2.
5
Real-World Treatment Outcomes in Black, Hispanic, Asian, and White People with Multiple Sclerosis Treated with Fumarates in the USA.美国使用富马酸盐治疗的黑人、西班牙裔、亚裔和白人多发性硬化症患者的真实世界治疗结果
Neurol Ther. 2025 Jun 16. doi: 10.1007/s40120-025-00773-3.
6
Rationale for a 4-month, parallel-group, randomized controlled trial to assess the Feasibility and Efficacy of a Remotely delivered exercise training intervention for Hispanics/Latinos with Multiple Sclerosis (FERLA MS).一项为期4个月的平行组随机对照试验的原理,该试验旨在评估针对患有多发性硬化症的西班牙裔/拉丁裔人群的远程运动训练干预措施(FERLA MS)的可行性和有效性。
Pilot Feasibility Stud. 2025 May 8;11(1):62. doi: 10.1186/s40814-025-01641-5.
7
Evaluation of Multiple Sclerosis Care and Its Impact on Brain Health: A United Arab Emirates Center Experience.多发性硬化症护理评估及其对脑健康的影响:阿联酋某中心的经验
Cureus. 2025 Mar 25;17(3):e81201. doi: 10.7759/cureus.81201. eCollection 2025 Mar.
8
Detecting New Lesions Using a Large Language Model: Applications in Real-World Multiple Sclerosis Datasets.使用大语言模型检测新病变:在真实世界多发性硬化症数据集中的应用
Ann Neurol. 2025 Aug;98(2):308-316. doi: 10.1002/ana.27251. Epub 2025 Apr 25.
9
Characterizing the diversity of the multiple sclerosis population in Canada: A scoping review.加拿大多发性硬化症患者群体的多样性特征:一项范围综述。
Mult Scler J Exp Transl Clin. 2025 Mar 17;11(1):20552173251321814. doi: 10.1177/20552173251321814. eCollection 2025 Jan-Mar.
10
The impact of social determinants of health on chronic kidney disease risk: evidence from the CHARLS study.健康的社会决定因素对慢性肾病风险的影响:来自中国健康与养老追踪调查(CHARLS)研究的证据
Front Public Health. 2025 Mar 4;13:1532372. doi: 10.3389/fpubh.2025.1532372. eCollection 2025.
BMJ Glob Health. 2022 May;7(5). doi: 10.1136/bmjgh-2022-008524.
4
Brain health: The hidden casualty of a humanitarian crisis.脑健康:人道主义危机中被忽视的受害者。
Lancet Reg Health Eur. 2022 Mar 22;15:100374. doi: 10.1016/j.lanepe.2022.100374. eCollection 2022 Apr.
5
Racial and Ethnic Disparities in Multiple Sclerosis Prevalence.多发性硬化症患病率的种族和民族差异。
Neurology. 2022 May 3;98(18):e1818-e1827. doi: 10.1212/WNL.0000000000200151.
6
Defining the determinants of vaccine uptake and undervaccination in migrant populations in Europe to improve routine and COVID-19 vaccine uptake: a systematic review.定义欧洲移民人群中疫苗接种率和疫苗接种不足的决定因素,以提高常规疫苗和 COVID-19 疫苗接种率:系统评价。
Lancet Infect Dis. 2022 Sep;22(9):e254-e266. doi: 10.1016/S1473-3099(22)00066-4. Epub 2022 Apr 13.
7
The influence of socioeconomic factors on access to disease modifying treatment in a Norwegian multiple sclerosis cohort.社会经济因素对挪威多发性硬化症队列中疾病修正治疗获得的影响。
Mult Scler Relat Disord. 2022 May;61:103759. doi: 10.1016/j.msard.2022.103759. Epub 2022 Mar 24.
8
Digital Inclusion as Health Care - Supporting Health Care Equity with Digital-Infrastructure Initiatives.数字包容作为医疗保健——通过数字基础设施举措支持医疗保健公平性。
N Engl J Med. 2022 Mar 24;386(12):1101-1103. doi: 10.1056/NEJMp2115646. Epub 2022 Mar 19.
9
The impact of the Australian Black Summer Bushfires and the COVID-19 pandemic on wellbeing in persons with multiple sclerosis; preparation for future and ongoing crises.澳大利亚黑色夏季丛林大火和 COVID-19 大流行对多发性硬化症患者的福祉的影响;为未来和持续的危机做准备。
Disabil Rehabil. 2023 Feb;45(4):630-643. doi: 10.1080/09638288.2022.2037756. Epub 2022 Feb 15.
10
Systematic Review of the Socioeconomic Consequences in Patients With Multiple Sclerosis With Different Levels of Disability and Cognitive Function.对不同残疾程度和认知功能水平的多发性硬化症患者社会经济后果的系统评价
Front Neurol. 2022 Jan 6;12:737211. doi: 10.3389/fneur.2021.737211. eCollection 2021.